About CellFE
CellFE is a company based in Berkeley (United States) founded in 2018 by Todd Sulchek and Alexander Alexeev.. CellFE has raised $26.8 million across 4 funding rounds from investors including Khosla Ventures, HHS and Elm Street Ventures. CellFE offers products and services including Ryva™ System, Ryva™ PUPs, and CellFE System. CellFE operates in a competitive market with competitors including Candel Therapeutics, StrideBio, Genedit, Phase Genomics and Genenta Science, among others.
- Headquarter Berkeley, United States
- Founders Todd Sulchek, Alexander Alexeev
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cellfe, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.8 M (USD)
in 4 rounds
-
Latest Funding Round
$22 M (USD), Series A
Sep 27, 2023
-
Investors
Khosla Ventures
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CellFE
CellFE offers a comprehensive portfolio of products and services, including Ryva™ System, Ryva™ PUPs, and CellFE System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Benchtop tool for cell therapy research and process development.
Components supporting gene editing and cell processing workflows.
Device for high-yield, scalable cell therapy manufacturing.
Unlock access to complete
Funding Insights of CellFE
CellFE has successfully raised a total of $26.8M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $22.0M
-
First Round
First Round
(15 Aug 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series A - CellFE | Valuation | M Ventures | |
| May, 2020 | Amount | Grant - CellFE | Valuation |
investors |
|
| Mar, 2020 | Amount | Seed - CellFE | Valuation | Cota Capital , Dynamk Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CellFE
CellFE has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, HHS and Elm Street Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage big data, health tech, AI, food tech, and multiple sectors
|
Founded Year | Domain | Location | |
|
Riverine Ventures is focused on life science and healthcare investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CellFE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CellFE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellfe Comparisons
Competitors of CellFE
CellFE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candel Therapeutics, StrideBio, Genedit, Phase Genomics and Genenta Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Viral immunotherapies are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
AAV-based gene therapies for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| domain | founded_year | HQ Location |
Lentivirus-based gene and cell therapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellfe
Frequently Asked Questions about CellFE
When was CellFE founded?
CellFE was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is CellFE located?
CellFE is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is CellFE a funded company?
CellFE is a funded company, having raised a total of $26.8M across 4 funding rounds to date. The company's 1st funding round was a Seed of $4.8M, raised on Aug 15, 2019.
What does CellFE do?
Founded in 2018 and based in Berkeley, United States, CellFE operates in the biotechnology sector. A microfluidic device is provided by the company to deliver gene-editing molecules into human cells. Cell therapies for various disorders are being developed through this platform. Operations focus on advancing intracellular delivery technologies for therapeutic applications.
Who are the top competitors of CellFE?
CellFE's top competitors include Phase Genomics, Genenta Science and Genedit.
What products or services does CellFE offer?
CellFE offers Ryva™ System, Ryva™ PUPs, and CellFE System.
Who are CellFE's investors?
CellFE has 10 investors. Key investors include Khosla Ventures, HHS, Elm Street Ventures, M-Ventures, and GreatPoint Ventures.